The widespread activation of YAP/TAZ in human cancer indicates that in addition to some of the relationships mentioned above, the upstream MST1/2 kinase and LATS1/2 kinase, the downstream binding factor TEADs, YAP/TAZ itself, and the interaction between YAP/TAZ and TEADs may be exploited as targets for cancer therapy. Here, LATS1 is linked to cancer.